Correlation between Banff classification and reversal of acute renal rejection.
Kokado
Y
Y
Department of Urology, Osaka University Medical School, Japan.
Kyo
M
M
Takahara
S
S
Ichimaru
N
N
Wang
J D
JD
Toki
K
K
Miki
T
T
Okuyama
A
A
D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006084:Graft Rejection / Q000145:classification* / Q000188:drug therapy / Q000473:pathology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; C037258:gusperimus; D008775:Methylprednisolone